|
|
Natco has pushed 1.25 million capsules of its anti-swine flu drug, Natco, in Indian pharmaceutical market to help people combat the lethal swine flu infection. The company also added that 10 million capsules will be made available by mid-October.
"We have launched Natflu capsules (generic version of Tamiflu - Oseltamivir), the first cure for swine flu to be available against medical prescription at designated chemists across India," said V.C. Nannapaneni, chairman of Natco, a Hyderabad-based pharma company.
"You know swine flu has spread in India. We have launched 1.25 millions capsules of swine flu drug Natflu," K. Srivastava, head of sales of the company told IANS.
More than 9,000 people have been reported to be tested positive for this epidemic in India. H1N1/A has also claimed the lives of 280 people across India.
Natco has mentioned that it has received the approval of the government to go ahead with the production and supply of these drugs, along with four other firms.
"The government said the tender will be equally distributed among five parties and we are ready to supply any number of doses to the government."
Natco Pharma said it has manufacturing facilities in Andhra Pradesh and Dehradun and employs around 2,000 people. These drugs will be available over-the-counter from Medplus, which is a chemist retain chain, but only with medical prescription.
